Phase I/II study of CPT-11 in combination with LV2FU5 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5FU failure

被引：0
|
作者：
Rougier, P
Ychou, M
Seitz, JF
Bonnay, M
Mignard, D
Couteau, C
Armand, JP
Ducreux, M
机构：
[1] IGR,VILLEJUIF,FRANCE
[2] CTR VAL AURELLE,MONTPELLIER,FRANCE
[3] INST J PAOLI I CALMETTES,F-13009 MARSEILLE,FRANCE
[4] RPR FRANCE,MONTROUGE,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [41] Multiple-target chemotherapy (Lv-modulated 5-FU bolus and continuous infusion, oxaliplatin, Cpt-11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II study
    Bonetti, Andrea
    Zaninelli, Marta
    Durante, Emilia
    Fraccon, Anna Paola
    Franceschi, Tiziano
    Pasini, Felice
    Zustovich, Fable
    Brienza, Silvano
    TUMORI JOURNAL, 2006, 92 (05): : 389 - 395
  • [42] A bi-weekly schedule of irinotecan (CPT-11) and 5-fluorouracil (5-FU) in advanced colorectal cancer (ACRC): Phase I study.
    Morese, R
    Ricevuto, U
    Cannita, K
    Antonini, CGC
    Lanfiuti, BP
    Trapasso, T
    Porzio, G
    Marchetti, P
    Ficorella, C
    ANNALS OF ONCOLOGY, 2000, 11 : 71 - 71
  • [43] Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma
    Oliver F Bathe
    Scot Dowden
    Francis Sutherland
    Elijah Dixon
    Charles Butts
    David Bigam
    Barb Walley
    Dean Ruether
    Scott Ernst
    BMC Cancer, 4
  • [44] A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
    Glimelius, B.
    Sorbye, H.
    Balteskard, L.
    Bystrom, P.
    Pfeiffer, P.
    Tveit, K.
    Heikkila, R.
    Keldsen, N.
    Albertsson, M.
    Starkhammar, H.
    Garmo, H.
    Berglund, A.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 909 - 914
  • [45] Cisplatin /5-FU (DDP/FU) as 2nd-line chemotherapy after CPT-11 (Irinotecan) failure for patients with metastatic gastric adenocarcinoma
    Thuss-Patience, PC
    Kretzschmar, A
    Tilgner, J
    Charles, A
    Dörken, B
    Reichardt, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S149 - S150
  • [46] Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer
    Jacqueline Duffour
    Sophie Gourgou
    Françoise Desseigne
    Charles Debrigode
    Laurent Mineur
    Frédéric Pinguet
    Sylvain Poujol
    Patrick Chalbos
    Françoise Bressole
    Marc Ychou
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 383 - 389
  • [47] Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer
    Duffour, Jacqueline
    Gourgou, Sophie
    Desseigne, Francoise
    Debrigode, Charles
    Mineur, Laurent
    Pinguet, Frederic
    Poujol, Sylvain
    Chalbos, Patrick
    Bressole, Francoise
    Ychou, Marc
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 383 - 389
  • [48] A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer
    Glimelius, B.
    Sorbye, H.
    Balteskard, L.
    Bystrom, P.
    Pfeiffer, P.
    Tveit, K.
    Heikkila, R.
    Keldsen, N.
    Albertsson, M.
    Starkhammar, H.
    Berglund, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 167 - 167
  • [49] Sequential CPT-11 and 5FU as second-line treatment of metastatic colorectal cancer (CRC) in patients progressing after first-line 5FU-based chemotherapy.: Value of the polymorphic tandem repeat sequence of the thymidylate synthase promoter.
    Abad, A
    Moreno, I
    Navarro, M
    Manzano, JL
    Alonso, J
    Batista, M
    Gallen, M
    Centelle, M
    Valentí, J
    Tarón, M
    ANNALS OF ONCOLOGY, 2000, 11 : 45 - 45
  • [50] BIFRACTIONATED CPT-11 WITH LV5FU2 INFUSION (FOLFIRI-3) IN COMBINATION WITH BEVACIZUMAB FOLLOWED BY A CAPECITABINE AND BEVACIZUMAB MAINTENANCE THERAPY: A PHASE II STUDY IN FIRST-LINE METASTATIC COLORECTAL CANCERS
    Kim, C. H. S.
    Curti, E.
    Nguyen, T.
    Maurina, T.
    Lakkis, Z.
    Heyd, B.
    Dobi, E.
    Fratte, S.
    Winkfield, B.
    Borg, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 204 - 204
12345